1,323 followers
RT @FrontOncology: New research: RB1 aberrations predict outcomes of immune checkpoint inhibitor combination therapy in NSCLC: Introduction…
RT @FrontOncology: New research: RB1 aberrations predict outcomes of immune checkpoint inhibitor combination therapy in NSCLC: Introduction…
New research: RB1 aberrations predict outcomes of immune checkpoint inhibitor combination therapy in NSCLC: Introduction Immune checkpoint inhibitors (ICI) have changed the treatment of non-small cell lung cancer (NSCLC). Furthermore, compared… #oncology